Regenerex Pharma (RGPX) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
REGENEREX PHARMA, INC.  (OTC: RGPX)

Regenerex Pharma Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RGPX Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q3 MRQ) - 65.99 % 55.6 % 37.69 %
Gross Margin (Q3 TTM) - 67.72 % 54 % 37.54 %
Gross Profit Margin 5 Yr. Avg. - 64.39 % 53.76 % 33.44 %
EBITDA Margin (Q3 MRQ) - 25.01 % 22.59 % 24.37 %
EBITDA Margin (Q3 TTM) - 25.6 % 20.71 % 19.36 %
EBITDA Margin 5 Yr. Avg. - 47 % 31.89 % 22.83 %
Operating Margin (Q3 MRQ) - 19.73 % 18.44 % 16.53 %
Operating Margin (Q3 TTM) - 18.91 % 16.41 % 15.7 %
Operating Margin 5 Yr. Avg. - 15.55 % 14.41 % 17.09 %
Pre-Tax Profit Margin (Q3 MRQ) - 17.37 % 14.32 % 13.69 %
Pre-Tax Profit Margin (Q3 TTM) - 16.78 % 12.42 % 12.57 %
Pre-Tax Profit Margin 5 Yr. Avg. - 13.09 % 10.45 % 12.49 %
Net Margin (Q3 MRQ) - 13.32 % 10.86 % 10.7 %
Net Margin (Q3 TTM) - 15.09 % 10.58 % 10.16 %
Net Margin 5 Yr. Avg. - 6.22 % 6.23 % 9.95 %



Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q3 MRQ) - 13.13 % 12.41 % 10.11 %
Free Cash Flow Margin (Q3 TTM) - 16.83 % 13.68 % 8.88 %
Free Cash Flow Margin 5 Yr. Avg. - 20.2 % 15.38 % 14.46 %
Net Cash Flow Margin (Q3 MRQ) - -1.28 % 1.59 % 2.5 %
Net Cash Flow Margin (Q3 TTM) - 3.51 % 1.49 % 0.91 %
Net Cash Flow Margin 5 Yr. Avg. - 4.28 % 3.13 % 5.85 %
Effective Tax Rate (Q3 MRQ) - 24.28 % 24.58 % 22.14 %
Effective Tax Rate (Q3 TTM)